Heart Palpitations on Wegovy: What's Normal and What Isn't

Palpitations are listed as an uncommon side effect in the Wegovy prescribing information — they affect a minority of users and typically arise in the early dose-adjustment phase.
The most frequent trigger is dehydration: nausea and reduced food intake lower fluid levels, which the heart notices first.
Wegovy's cardiovascular trial (SELECT) actually showed a significant reduction in major cardiac events in people with obesity and established heart disease, the medicine's overall effect on the heart is protective at population level.
Persistent, severe, or fast palpitations with chest pain, breathlessness or fainting need urgent medical assessment, this is not a side effect to wait out at home.

Heart palpitations on Wegovy do occur, and the most common cause is not the medicine acting on your heart directly — it's the body's response to rapid fluid shifts and reduced calorie intake in the early weeks of treatment. Semaglutide itself is not a cardiac stimulant, and for most people the sensation is temporary. That said, not every palpitation is benign, and knowing the difference matters. These are prescription-only medicines assessed individually by a clinician; a prescriber reviews your cardiac history as part of any legitimate consultation before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding palpitations on semaglutide: causes, timing and what to do

The misconception: people assume Wegovy is stimulating the heart

When patients notice a fluttering or racing sensation in their chest after starting Wegovy, the instinct is to blame the medicine acting directly on cardiac tissue. That's understandable (the feeling is alarming) but it usually isn't what's happening. Semaglutide is a GLP-1 receptor agonist; its primary targets are the gut, the pancreas, and appetite-regulating areas of the brain. It does not work like a stimulant drug that speeds the heart as a direct mechanism.

What does cause palpitations in this context is usually downstream. Nausea and reduced appetite (both common in the first few weeks) lead people to eat and drink less than usual. Dehydration reduces blood volume, which the heart compensates for by beating faster or more forcefully. You notice this as a thump or flutter, particularly when standing up quickly or after exertion. Low food intake can also lower blood potassium and magnesium, both of which influence heart rhythm. These are indirect, manageable causes, not a sign the medicine is damaging your heart.

There is also a reassuring counterpoint worth stating clearly. The SELECT cardiovascular outcomes trial enrolled over 17,000 adults with obesity and established cardiovascular disease and found that semaglutide 2.4mg reduced the risk of major cardiac events (heart attack, stroke, cardiovascular death) by around 20% over roughly three years. The NHS's patient information on semaglutide documents palpitations as an uncommon side effect, meaning they occur in fewer than one in ten but more than one in a hundred people using the medicine. NHS guidance on semaglutide lists the full side-effect profile and is worth reading alongside your Patient Information Leaflet.

Why the timing of palpitations tells you a lot

Most semaglutide-related palpitations follow a predictable pattern: they appear in the first one to four weeks of a new dose, peak around the time nausea is at its worst, and then settle as the body adjusts. If you're experiencing them now, there's a reasonable chance you're in this window, and the practical response is focused on hydration and eating enough to maintain electrolyte balance, not stopping the medicine.

Sipping fluids steadily through the day, favouring foods with some sodium and potassium (soups, bananas, yoghurt), and avoiding sudden posture changes when the feeling is strong can all reduce the intensity. Your prescriber may also ask whether you're taking any other medicines that affect heart rate or rhythm, antihistamines, decongestants, and some blood pressure drugs interact in ways that make palpitations more likely. If you're considering the broader cardiac effects of the medicine, our page on Wegovy and heart health covers the evidence in more detail.

Palpitations that arrive weeks into treatment, long after the initial adjustment, are a different matter. So are episodes that come on suddenly at rest, last more than a few minutes, or happen repeatedly without an obvious trigger. These deserve a call to your GP or prescriber the same day rather than a watchful wait.

When to get medical help, and what to tell your doctor

This is the most important section on this page. Seek urgent medical attention if palpitations are accompanied by any of the following: chest tightness or pain, breathlessness at rest, dizziness or fainting, a heart rate that feels very fast and won't slow down, or a sensation of the heart stopping and restarting. Call 999 if the symptoms are severe or sudden. These presentations go beyond what dehydration or a dose adjustment explains.

You should also be aware that the MHRA monitors all medicines through its Yellow Card scheme. If you experience a side effect you consider serious or unexpected (including cardiac symptoms) you can report it directly at yellowcard.mhra.gov.uk. These reports help regulators detect patterns that inform prescribing guidance.

When speaking to any clinician about palpitations on Wegovy, it helps to note the timing (after eating, at rest, on standing), the duration, how fast the heart felt, and whether anything triggered or relieved it. Mention your current dose and when you last increased it. If your resting heart rate has changed noticeably since starting treatment, that context matters too, and if you are pregnant or planning a pregnancy, our guidance on getting pregnant on Wegovy is also relevant to share with your clinician.

Private treatment and what a clinical review covers

One reason palpitations catch people off guard is that some online prescribers do very little in the way of upfront assessment. A legitimate clinical review before starting Wegovy should include your cardiac history, current medicines, and blood pressure. At nume, a GPhC-registered Independent Prescriber reads your answers personally (a real clinician, not an automated form) and flags anything in your history that would affect how safely you can use semaglutide.

If cost is part of the picture for you, the Wegovy price comparison page covers what's typically included in a private prescription and what isn't. On the Wegovy overview, you'll find broader information about how the treatment works and who it's licensed for. The right starting point, if you haven't yet begun treatment or want a review of your current one, is a free consultation with our prescribers.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions